BAUSCH HEALTH COS INC (BHC)
CA0717341071 - Common Stock
BHC May 31st Options Begin Trading
May 10th Options Now Available For Bausch Health Companies (BHC)
April 5th Options Now Available For Bausch Health Companies (BHC)
Bausch + Lomb stock gains after Q4 earnings beat (NYSE:BLCO)
Bausch + Lomb (BLCO) exceeds Q4 2023 expectations and predicts strong financial performance for 2024 with revenue exceeding forecasts. Read more here.
Interesting BHC Put And Call Options For May 17th
March 22nd Options Now Available For Bausch Health Companies (BHC)
Bausch + Lomb stock downgraded at J.P. Morgan (NYSE:BLCO)
J.P. Morgan downgrades eyecare company Bausch + Lomb (BLCO) due to risks related to its planned spinoff from parent company Bausch Health (BHC). Read more here.
Bausch gets Chinese approval for Thermage FLX and TR-4 return pad (NYSE:BHC)
Chinese regulators have approved Soltera's Thermage FLX and TR-4 return pad for the treatment of wrinkles. Soltera is a unit of Bausch Health (BHC). Read more here.
March 15th Options Now Available For Bausch Health Companies (BHC)
March 1st Options Now Available For Bausch Health Companies (BHC)
Bausch Health stock gains after an appeals hearing in Norwich case over generic Xifaxan
Bausch Health's shares rise after appeals hearing in patent case over Xifaxan, with positive litigation updates potentially leading to a BLCO spin.
BHC Crosses Above Key Moving Average Level
Bausch reports positive Phase 2 data for ulcerative colitis drug (NYSE:BHC)
Bausch Health (BHC) reported positive results from a Phase 2 study of its drug Amiselimod in the treatment of ulcerative colitis. Read more here.
Bausch Health Companies Inc. (NYSE:BHC) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 12/01/2023 -- An investigation on behalf of current long-term investors in shares of Bausch Health Companies Inc. (NYSE:BHC) concerning potential breaches of fiduciary duties by certain directors and officers of Bausch Health Companies Inc. was announced.
Bausch Health swings to quarterly loss on goodwill impairments, higher expenses (NYSE:BHC)
Bausch Health (BHC) on Thursday said it swung to a quarterly loss from a profit a year ago. Read more here.
(NYSE:BHC)
Bausch Health Companies exceeded expectations in their Q3 earnings report with higher than projected earnings per share and revenue.
Bausch Health stock gains amid victory in Norwich case over generic Xifaxan
Bausch Health (BHC) gains 4% as it wins a lawsuit against Norwich Pharma over its bowel disease therapy Xifaxan, denying preliminary injunction.
Bausch Health gets FDA approval for acne treatment Cabtreo (NYSE:BHC)
Bausch Health (BHC) receives FDA approval for Cabtreo, a triple-combination topical medication for the treatment of acne in patients aged 12 and older. Read more here.
Oversold Conditions For Bausch Health Companies (BHC)
BHC November 24th Options Begin Trading
BHC FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
WHY: NEW YORK, NY - (NewMediaWire) - September 23, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bausch Health Companies Inc. (NYSE: BHC) between August 6, 2020 and May 3, 2023, both dates inclusive (the “Class Period”), of the important September 25, 2023 lead plaintiff deadline.
BHC FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bausch Health Companies Inc. (BHC)
BHC DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bausch Health Companies Inc. (NYSE: BHC) between...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC). Such...
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Bausch Health Companies Inc.(BHC) Investors of a Class Action Lawsuit and Upcoming Deadline
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC) of a class action securities...
Bausch Health stock rebounds from Tuesday sell-off, helped by Jefferies upgrade (NYSE:BHC)
Bausch Health Companies (BHC) shares were on the rebound Wednesday morning, helped by an upgrade from Jefferies, after sinking Tuesday on news that the company’s CFO was leaving.
Why Bausch Health Stock Is Jumping Today
Investors appear to be shaking off their concerns about Bausch Health's CFO turnover.